An Efficient Algorithm to Determine the Optimal Two-Stage Randomized Multinomial Designs in Oncology Clinical Trials

Author： Zhang Yong   Mietlowski William   Chen Bee   Wang Yibin  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.21, Iss.1, 2011-01, pp. : 56-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Two-Stage Randomized Multinomial Designs for Phase II Oncology Trials

By Sun Linda  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 485-493

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Two-Stage Designs Allowing Flexibility in Number of Subjects for Phase II Clinical Trials

By Masaki Nobuyuki  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 721-731

Taylor & Francis Ltd

Access to resources Recommend Favorite

Randomized Two-Stage Phase II Clinical Trial Designs Based on Barnard's Exact Test

By Shan Guogen   Ma Changxing   Hutson Alan D.   Wilding Gregory E.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1081-1090

Taylor & Francis Ltd

Access to resources Recommend Favorite

Analysis of Time-to-Event Data Under a Two-Stage Survival Adaptive Design in Clinical Trials

By Lu Qingshu  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 4, 2010-07 ,pp. : 705-719

Taylor & Francis Ltd

Access to resources Recommend Favorite

Familywise Error Control in Multi-Armed Response-Adaptive Two-Stage Designs

By Gutjahr Georg  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 818-830

Taylor & Francis Ltd

Access to resources Recommend Favorite